A study to investigate the effect of pioglitazone on whole body and myocardial glucose uptake and myocardial blood flow/coronary vasodilator reserve in patients with familial combined hyperlipidaemia
Phase of Trial: Phase II
Latest Information Update: 01 Sep 2007
At a glance
- Drugs Pioglitazone (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacodynamics
- Sponsors Takeda Europe Research & Development Centre
- 01 Sep 2007 Results reported in an abstract from the proceedings of the ESC Congress 2007: Annual Congress of the European Society of Cardiology, 01 Sep 2007.
- 20 Sep 2006 New trial record.